BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.63B |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$337M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$172M |
| 4 |
PPG Industries
PPG
|
+$132M |
| 5 |
AGN
Allergan plc
AGN
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$750M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$525M |
| 3 |
Apple
AAPL
|
+$317M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$275M |
| 5 |
McDonald's
MCD
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.55% |
| 2 | Financials | 8.18% |
| 3 | Healthcare | 5.72% |
| 4 | Consumer Discretionary | 5.19% |
| 5 | Communication Services | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRG
3201
Seritage Growth Properties
SRG
$128M
| $23.3K | ﹤0.01% |
+626
| New | +$24.8K |
|
|
PPS
3202
DELISTED
Post Properties
PPS
| $23.1K | ﹤0.01% |
397
-7,621
| -95% | -$436K |
|
|
RNWK
3203
DELISTED
RealNetworks Inc
RNWK
| $23.1K | ﹤0.01% |
5,639
+3,710
| +192% | +$16.8K |
|
|
AL
3204
DELISTED
Air Lease Corp
AL
| $23K | ﹤0.01% |
744
-1,440
| -66% | -$47.9K |
|
3205
Popular Inc
BPOP
$11.3B
| $22.7K | ﹤0.01% |
751
-7,077
| -90% | -$212K |
|
3206
Vaalco Energy
EGY
$592M
| $22.7K | ﹤0.01% |
13,335
-24,410
| -65% | -$40.1K |
|
|
STCN
3207
DELISTED
Steel Connect, Inc. Common Stock
STCN
| $22.3K | ﹤0.01% |
836
+500
| +149% | +$14.7K |
|
3208
Healthcare Realty
HR
$6.59B
| $22.3K | ﹤0.01% |
909
-17,390
| -95% | -$429K |
|
3209
W&T Offshore
WTI
$546M
| $22.2K | ﹤0.01% |
7,415
-670
| -8% | -$2.49K |
|
|
RFP
3210
DELISTED
Resolute Forest Products Inc.
RFP
| $22.2K | ﹤0.01% |
2,671
-206
| -7% | -$2K |
|
|
PZN
3211
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $22.2K | ﹤0.01% |
2,493
+1,447
| +138% | +$14.4K |
|
3212
Preformed Line Products
PLPC
$2.19B
| $22.2K | ﹤0.01% |
597
+376
| +170% | +$13K |
|
3213
Eledon Pharmaceuticals
ELDN
$285M
| $22.1K | ﹤0.01% |
13
+8
| +160% | +$16.5K |
|
|
MHGC
3214
DELISTED
Morgans Hotel Group Co.
MHGC
| $22.1K | ﹤0.01% |
6,647
+4,391
| +195% | +$22.3K |
|
3215
Enovis
ENOV
$1.48B
| $22K | ﹤0.01% |
428
-819
| -66% | -$54.3K |
|
|
PGRE
3216
DELISTED
Paramount Group
PGRE
| $21.9K | ﹤0.01% |
1,306
-23,028
| -95% | -$398K |
|
|
VAL
3217
DELISTED
Valspar
VAL
| $21.9K | ﹤0.01% |
304
+230
| +311% | +$18K |
|
3218
Prospect Capital
PSEC
$1.18B
| $21.8K | ﹤0.01% |
3,059
| – | – |
|
|
NEOS
3219
DELISTED
Neos Therapeutics, Inc
NEOS
| $21.5K | ﹤0.01% |
+1,024
| New | +$22.6K |
|
|
CMLS
3220
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $21.3K | ﹤0.01% |
3,806
+2,323
| +157% | +$26.3K |
|
3221
Protara Therapeutics
TARA
$232M
| $21.3K | ﹤0.01% |
38
+22
| +138% | +$13.6K |
|
3222
John Wiley & Sons Class A
WLY
$2.63B
| $21.3K | ﹤0.01% |
425
-6,202
| -94% | -$322K |
|
3223
Brown-Forman Class A
BF.A
$13.1B
| $21.2K | ﹤0.01% |
495
-960
| -66% | -$43.1K |
|
|
IHC
3224
DELISTED
Independence Holding Company
IHC
| $21.1K | ﹤0.01% |
1,629
+1,043
| +178% | +$13.4K |
|
3225
Enphase Energy
ENPH
$5.39B
| $21.1K | ﹤0.01% |
5,701
+3,408
| +149% | +$18.1K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2015 Portfolio in Review
As of Q3 2015, BNP Paribas Financial Markets held 3,791 positions worth $39.9B, up 11% from $35.8B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
BNP Paribas Financial Markets deployed $7.43B of net new capital in Q3 2015, opening 248 new positions and adding to 2,429 existing holdings. Its largest new stake was Allergan plc: 397,434 shares worth $108M.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 10% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $525M trimmed.
- BNP Paribas Financial Markets's largest Q3 2015 buy was Allergan plc: 397,434 shares worth $108M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $5.63B increase.
- BNP Paribas Financial Markets's biggest Q3 2015 reduction was iShares Russell 2000 ETF, cutting an estimated $525M.
- BNP Paribas Financial Markets fully exited Canadian National Railway in Q3 2015, selling an estimated $750M.
- BNP Paribas Financial Markets's ten largest holdings make up 45% of its $39.9B portfolio in Q3 2015.
- BNP Paribas Financial Markets opened 248 new positions and closed 172 in Q3 2015.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $39.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2015, filed 13 Nov 2015.